The glycylcyclines: a comparative review with the tetracyclines
about
A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744].Tigecycline: a review of a new glycylcycline antibioticA Modified Murine Embryonic Stem Cell Test for Evaluating the Teratogenic Effects of Drugs on Early EmbryogenesisPharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsPharmacokinetic profile of tigecycline in serum and skin blister fluid of healthy subjects after multiple intravenous administrationsEfflux pumps as antimicrobial resistance mechanisms.Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline.Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics.In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis.Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic model.Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.Rapid development of Acinetobacter baumannii resistance to tigecycline.Acute pancreatitis related to tigecycline: case report and review of the literature.Potential role of tigecycline in the treatment of community-acquired bacterial pneumonia.Tigecycline pharmacokinetics, tolerability, safety, and effect on intestinal microflora in healthy Japanese male subjects.Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infections.Drug discovery from natural sources.Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections.New advances in antibiotic development and discovery.Antibiotic prescribing as a risk factor for MRSA.Excess deaths associated with tigecycline after approval based on noninferiority trials.Efflux-mediated antimicrobial resistance.Tigecycline: a new glycylcycline for treatment of serious infections.Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.The search for new antimicrobials: why we need new options.Novel approaches to developing new antibiotics for bacterial infections.Tigecycline for the treatment of infections due to resistant Gram-positive organisms.Role of mycobacterial efflux transporters in drug resistance: an unresolved question.Tigecycline: a novel glycylcycline antibiotic.Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Effects of minocycline and valproic acid coadministration on atazanavir plasma concentrations in human immunodeficiency virus-infected adults receiving atazanavir-ritonavir.Antimicrobial susceptibility among Gram-positive organisms collected from pediatric patients globally between 2004 and 2011: results from the Tigecycline Evaluation and Surveillance Trial.Stability of Doxycycline in Feed and Water and Minimal Effective Doses in Tetracycline-Inducible Systems.Resistance mutations generate divergent antibiotic susceptibility profiles against translation inhibitorsThe role of doxycycline in the therapy of multidrug-resistant E. coli - an in vitro study.Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureusSynthesis and antibacterial activity of doxycycline neoglycosides.Establishing the role of tigecycline in an era of antimicrobial resistance.Antimalarial activity of tigecycline, a novel glycylcycline antibiotic.
P2860
Q24813784-ADD927E2-3722-46EC-8EE5-FC0B1AF3E638Q28278979-83775033-D2E6-46AA-BBAA-E20B7E652ABAQ28551650-88077220-D832-4E1B-945D-FEC69528EF93Q29398341-3812AB85-12F1-4796-A9D3-3F52E74B1CE9Q33722056-B107C197-A75E-45A4-AC13-5A9B2686BECDQ34003782-4780065B-DD10-4A27-B7F1-D57640C53665Q34133346-9BB2CD19-527E-494B-8D95-D0A4523D3737Q34509292-B8DCEB35-288A-450A-816A-6BC544D10195Q34510538-89B3B2C2-BEF0-4F5A-BFC5-3B3AC04B74D9Q34510589-99C4B3BF-8860-4541-9B19-3D75858ABB0FQ34513298-A395D8CC-5EFF-4334-B45F-18854D752159Q34581377-A16535A8-7D24-4551-96B8-52D01523E24FQ34599630-C4ABD6EA-F862-4F54-A0BC-0D78E8AC08E6Q35026616-429950B8-B29F-4661-A11B-B8273184D521Q35045248-C0CB7C1A-47AB-416E-8E72-8DFE60B696F9Q35127941-C3475C31-A878-48D9-9733-E1E6A732A0D2Q35594873-0A89F3F9-C05B-4FC6-9B2B-5FF3E4BA2EC9Q35876393-B2E0242A-9C5E-4EB0-8EB0-4990450AE044Q36065983-FDA7F30E-8CCE-402A-B9B9-205717360450Q36080672-221DB78F-F541-4A93-8D44-BB1CDB9A4919Q36115632-FC05FA5D-AF20-4149-BB96-D09B2E0C7768Q36138147-42A120ED-12F7-416E-B8DC-7A3F7379F83CQ36218312-AC13C501-7675-45AA-96B1-D5CFF5043145Q36312071-A0BD8563-6077-4846-94E4-7275D10C7497Q36322113-4B7A0438-DC2C-4B2E-B317-9EE8D3A45F7AQ36358643-17EC08CB-2D05-4DAC-9279-29E1AE76F56EQ36376443-23C19BF1-BE23-4FB9-A32C-412415A89BD0Q36378353-EFB60840-3029-4721-94A8-80684B018049Q36379330-1F8B9850-EAD7-49BF-A838-84272F5F4E4DQ36663656-48664621-4B2A-4AE7-A049-79F1C7D856BEQ36718474-D23848D8-E59E-4837-8195-315BC750188EQ36870884-7196362D-1BF2-44BC-8047-F6B26FF9ADF7Q36971026-E01DEEC1-4792-4402-8190-36B615EF93DAQ37091824-9B0589AD-280C-44ED-B3DC-24C29128651FQ37126692-2A4DC632-8383-4B8C-AFF8-0E61EDBDB64BQ37184911-8E822A90-A307-4055-9B51-C68F43B2FA52Q37247619-AD3CA56F-F339-41B9-A1DE-6163E6A38EF2Q37270510-F28531AA-405E-49BC-9F30-6EE4DD7C679AQ37291328-7417953C-E6D5-42A4-99B2-5318980B6A0DQ37333066-5DC38242-FCC0-40FB-8B3A-2AD3448600E1
P2860
The glycylcyclines: a comparative review with the tetracyclines
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The glycylcyclines: a comparative review with the tetracyclines
@ast
The glycylcyclines: a comparative review with the tetracyclines
@en
The glycylcyclines: a comparative review with the tetracyclines
@nl
type
label
The glycylcyclines: a comparative review with the tetracyclines
@ast
The glycylcyclines: a comparative review with the tetracyclines
@en
The glycylcyclines: a comparative review with the tetracyclines
@nl
prefLabel
The glycylcyclines: a comparative review with the tetracyclines
@ast
The glycylcyclines: a comparative review with the tetracyclines
@en
The glycylcyclines: a comparative review with the tetracyclines
@nl
P2093
P3181
P1433
P1476
The glycylcyclines: a comparative review with the tetracyclines
@en
P2093
Alfred Gin
Ayman Noreddin
Daryl J Hoban
James A Karlowsky
John Embil
Kim Nichol
Kristen Homenuik
P3181
P356
10.2165/00003495-200464010-00005
P407
P577
2004-01-01T00:00:00Z
P6179
1023519272